OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
mRNA vaccination as a safe approach for specific protection from type I allergy
Richard Weiss, Sandra Scheiblhofer, Elisabeth Roesler, et al.
Expert Review of Vaccines (2011) Vol. 11, Iss. 1, pp. 55-67
Closed Access | Times Cited: 39
Richard Weiss, Sandra Scheiblhofer, Elisabeth Roesler, et al.
Expert Review of Vaccines (2011) Vol. 11, Iss. 1, pp. 55-67
Closed Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
Nonviral delivery of self-amplifying RNA vaccines
Andrew J. Geall, Ayush Verma, Gillis R. Otten, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 36, pp. 14604-14609
Open Access | Times Cited: 592
Andrew J. Geall, Ayush Verma, Gillis R. Otten, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 36, pp. 14604-14609
Open Access | Times Cited: 592
Materials for non-viral intracellular delivery of messenger RNA therapeutics
Kevin Kauffman, Matthew J. Webber, Daniel G. Anderson
Journal of Controlled Release (2015) Vol. 240, pp. 227-234
Closed Access | Times Cited: 341
Kevin Kauffman, Matthew J. Webber, Daniel G. Anderson
Journal of Controlled Release (2015) Vol. 240, pp. 227-234
Closed Access | Times Cited: 341
mRNA transcript therapy
Drew Weissman
Expert Review of Vaccines (2014) Vol. 14, Iss. 2, pp. 265-281
Closed Access | Times Cited: 193
Drew Weissman
Expert Review of Vaccines (2014) Vol. 14, Iss. 2, pp. 265-281
Closed Access | Times Cited: 193
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
Raquel P. Deering, Sushma Kommareddy, Jeffrey B. Ulmer, et al.
Expert Opinion on Drug Delivery (2014) Vol. 11, Iss. 6, pp. 885-899
Closed Access | Times Cited: 172
Raquel P. Deering, Sushma Kommareddy, Jeffrey B. Ulmer, et al.
Expert Opinion on Drug Delivery (2014) Vol. 11, Iss. 6, pp. 885-899
Closed Access | Times Cited: 172
RNA-based vaccines
Jeffrey B. Ulmer, Peter W. Mason, Andrew J. Geall, et al.
Vaccine (2012) Vol. 30, Iss. 30, pp. 4414-4418
Closed Access | Times Cited: 168
Jeffrey B. Ulmer, Peter W. Mason, Andrew J. Geall, et al.
Vaccine (2012) Vol. 30, Iss. 30, pp. 4414-4418
Closed Access | Times Cited: 168
Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion
Willy Bogers, Herman Oostermeijer, Petra Mooij, et al.
The Journal of Infectious Diseases (2014) Vol. 211, Iss. 6, pp. 947-955
Open Access | Times Cited: 165
Willy Bogers, Herman Oostermeijer, Petra Mooij, et al.
The Journal of Infectious Diseases (2014) Vol. 211, Iss. 6, pp. 947-955
Open Access | Times Cited: 165
RNA Nanotechnology-Mediated Cancer Immunotherapy
Yao‐Xin Lin, Yì Wáng, Sara Blake, et al.
Theranostics (2019) Vol. 10, Iss. 1, pp. 281-299
Open Access | Times Cited: 139
Yao‐Xin Lin, Yì Wáng, Sara Blake, et al.
Theranostics (2019) Vol. 10, Iss. 1, pp. 281-299
Open Access | Times Cited: 139
Self-replicating alphavirus RNA vaccines
Karl Ljungberg, Peter Liljeström
Expert Review of Vaccines (2014) Vol. 14, Iss. 2, pp. 177-194
Closed Access | Times Cited: 132
Karl Ljungberg, Peter Liljeström
Expert Review of Vaccines (2014) Vol. 14, Iss. 2, pp. 177-194
Closed Access | Times Cited: 132
mRNA vaccines: the most recent clinical applications of synthetic mRNA
Suji Kwon, Minseon Kwon, Seongeun Im, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 4, pp. 245-262
Open Access | Times Cited: 50
Suji Kwon, Minseon Kwon, Seongeun Im, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 4, pp. 245-262
Open Access | Times Cited: 50
Microbiome, sex hormones, and immune responses in the reproductive tract: Challenges for vaccine development against sexually transmitted infections
Rebecca M. Brotman, Jacques Ravel, Patrik M. Bavoil, et al.
Vaccine (2013) Vol. 32, Iss. 14, pp. 1543-1552
Open Access | Times Cited: 101
Rebecca M. Brotman, Jacques Ravel, Patrik M. Bavoil, et al.
Vaccine (2013) Vol. 32, Iss. 14, pp. 1543-1552
Open Access | Times Cited: 101
A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
Karl‐Josef Kallen, Andreas Theß
Therapeutic Advances in Vaccines (2013) Vol. 2, Iss. 1, pp. 10-31
Open Access | Times Cited: 99
Karl‐Josef Kallen, Andreas Theß
Therapeutic Advances in Vaccines (2013) Vol. 2, Iss. 1, pp. 10-31
Open Access | Times Cited: 99
Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
Alicia Rodríguez‐Gascón, Ana del Pozo‐Rodríguez, Maria Ángelés Solinís
International Journal of Nanomedicine (2014), pp. 1833-1833
Open Access | Times Cited: 77
Alicia Rodríguez‐Gascón, Ana del Pozo‐Rodríguez, Maria Ángelés Solinís
International Journal of Nanomedicine (2014), pp. 1833-1833
Open Access | Times Cited: 77
Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond
Britta Vallazza, Sebastian Petri, Marco A. Poleganov, et al.
Wiley Interdisciplinary Reviews - RNA (2015) Vol. 6, Iss. 5, pp. 471-499
Closed Access | Times Cited: 71
Britta Vallazza, Sebastian Petri, Marco A. Poleganov, et al.
Wiley Interdisciplinary Reviews - RNA (2015) Vol. 6, Iss. 5, pp. 471-499
Closed Access | Times Cited: 71
Poly(β‐amino ester)‐co‐poly(caprolactone) Terpolymers as Nonviral Vectors for mRNA Delivery In Vitro and In Vivo
Umberto Capasso Palmiero, James C. Kaczmarek, Owen S. Fenton, et al.
Advanced Healthcare Materials (2018) Vol. 7, Iss. 14
Open Access | Times Cited: 71
Umberto Capasso Palmiero, James C. Kaczmarek, Owen S. Fenton, et al.
Advanced Healthcare Materials (2018) Vol. 7, Iss. 14
Open Access | Times Cited: 71
DNA and mRNA vaccination against allergies
Sandra Scheiblhofer, Josef Thalhamer, Richard Weiss
Pediatric Allergy and Immunology (2018) Vol. 29, Iss. 7, pp. 679-688
Open Access | Times Cited: 71
Sandra Scheiblhofer, Josef Thalhamer, Richard Weiss
Pediatric Allergy and Immunology (2018) Vol. 29, Iss. 7, pp. 679-688
Open Access | Times Cited: 71
mRNA-based therapeutics–Advances and perspectives
Olga V. Sergeeva, V.E. Koteliansky, Timofei S. Zatsepin
Biochemistry (Moscow) (2016) Vol. 81, Iss. 7, pp. 709-722
Closed Access | Times Cited: 69
Olga V. Sergeeva, V.E. Koteliansky, Timofei S. Zatsepin
Biochemistry (Moscow) (2016) Vol. 81, Iss. 7, pp. 709-722
Closed Access | Times Cited: 69
Tolerogenic nanovaccines for the treatment of type I allergic diseases
Yueping Ren, Daoke Yao, Fang Wu, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 664-685
Closed Access
Yueping Ren, Daoke Yao, Fang Wu, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 664-685
Closed Access
Messenger RNA ‐based vaccines: progress, challenges, applications
Thomas Kramps, Jochen Probst
Wiley Interdisciplinary Reviews - RNA (2013) Vol. 4, Iss. 6, pp. 737-749
Closed Access | Times Cited: 46
Thomas Kramps, Jochen Probst
Wiley Interdisciplinary Reviews - RNA (2013) Vol. 4, Iss. 6, pp. 737-749
Closed Access | Times Cited: 46
Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP)
Fangjun Luo, Lina Zheng, Yue Hu, et al.
Frontiers in Microbiology (2017) Vol. 08
Open Access | Times Cited: 45
Fangjun Luo, Lina Zheng, Yue Hu, et al.
Frontiers in Microbiology (2017) Vol. 08
Open Access | Times Cited: 45
Synthetic mRNAs for manipulating cellular phenotypes: an overview
Elgar Susanne Quabius, Guido Krupp
New Biotechnology (2014) Vol. 32, Iss. 1, pp. 229-235
Open Access | Times Cited: 41
Elgar Susanne Quabius, Guido Krupp
New Biotechnology (2014) Vol. 32, Iss. 1, pp. 229-235
Open Access | Times Cited: 41
The messenger's great message for vaccination
Steve Pascolo
Expert Review of Vaccines (2015) Vol. 14, Iss. 2, pp. 153-156
Open Access | Times Cited: 39
Steve Pascolo
Expert Review of Vaccines (2015) Vol. 14, Iss. 2, pp. 153-156
Open Access | Times Cited: 39
Comparison of the Expression Kinetics and Immunostimulatory Activity of Replicating mRNA, Nonreplicating mRNA, and pDNA after Intradermal Electroporation in Pigs
Bregje Leyman, Hanne Huysmans, Séan Mc Cafferty, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 2, pp. 377-384
Closed Access | Times Cited: 28
Bregje Leyman, Hanne Huysmans, Séan Mc Cafferty, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 2, pp. 377-384
Closed Access | Times Cited: 28
Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice
E. Hattinger, Sandra Scheiblhofer, Elisabeth Roesler, et al.
Journal of Immunology Research (2015) Vol. 2015, pp. 1-12
Open Access | Times Cited: 25
E. Hattinger, Sandra Scheiblhofer, Elisabeth Roesler, et al.
Journal of Immunology Research (2015) Vol. 2015, pp. 1-12
Open Access | Times Cited: 25
The global mRNA vaccine patent landscape
Mengyao Li, Jianxiong Ren, Xingyong Si, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 11
Mengyao Li, Jianxiong Ren, Xingyong Si, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 11
Potential of nanoparticles for allergen-specific immunotherapy – use of silica nanoparticles as vaccination platform
Sandra Scheiblhofer, Yoan Machado, Andrea Feinle, et al.
Expert Opinion on Drug Delivery (2016) Vol. 13, Iss. 12, pp. 1777-1788
Closed Access | Times Cited: 18
Sandra Scheiblhofer, Yoan Machado, Andrea Feinle, et al.
Expert Opinion on Drug Delivery (2016) Vol. 13, Iss. 12, pp. 1777-1788
Closed Access | Times Cited: 18
